EXHIBITOR LISTING
Staff at company trade displays are precluded by Australian law from giving information about specific products to non-healthcare professionals
| Platinum 1 | Sanofi |
|---|---|
| Platinum 2 | CSL Seqirus |
| Exhibition Booth 1 & 2 | Moderna |
| Exhibition Booth 3 | GSK |
| Exhibition Booth 5 | GISAID |
| Exhibition Booth 6 | Roche |
| Exhibition Booth 7 | Pfizer |
| Exhibition Booth 8 | hVIVO |
| Exhibition Booth 9 | ESWI |
| Exhibition Booth 10 | AstraZeneca |
| Exhibition Booth 12 | Cellular Technology Limited |
| Exhibition Booth 13 & 14 | Vaxxas |
Platinum 1
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.
Scientific discoveries don't happen overnight or without hard work. But our determination to find answers for patients motivates us to develop breakthrough medicines and vaccines. And to never settle.
Learn more at sanofi.com.au.
Platinum 2
As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to public health through the prevention of influenza and pandemic preparedness. With state-of-the-art production facilities and leading R&D capabilities, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.
In Australia, CSL Seqirus operates the only manufacturing facility for seasonal and pandemic influenza vaccines, and produces a range of unique medicines in the national interest including antivenoms and the only human vaccine for Q fever. Our commitment to Australia's health also extends to providing access to paediatric and adult vaccines, and innovative pharmaceuticals for patients living with allergies, cardiovascular disease, severe pain, dry eye disease, iron deficiency, kidney diseases, rare diseases and neurological conditions.
Exhibition Booths 1 & 2
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines.
Moderna's mRNA platform is enabling the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets. Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com.
Exhibition Booth 3
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of more than 2.5 billion individuals by 2031, with ambitious plans for growth and continuing to make GSK a company where everyone can thrive.
Exhibition Booth 5
GISAID is known for providing transparent access to the world's largest collection of genomic and associated metadata of high-priority pathogens. With ~20 million curated viral genomes, GISAID remains an essential asset for the WHO GISRS-network enabling genomic surveillance for Influenza, RSV, SARS-CoV-2, in addition to Mpox and Arboviruses e.g. Dengue.
Exhibition Booth 6
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.
Exhibition Booth 7
Breakthroughs That Change Patients' Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
Exhibition Booth 8
hVIVO is a specialist contract research organisation and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials, providing end-to-end early drug development services (Venn Life Sciences), clinical experts in industry leader in virology clinical trial support (hLAB) and volunteer recruitment experts (FluCamp).
Exhibition Booth 9
The European Scientific Working group on Influenza and other Respiratory Viruses (ESWI) is a network organisation that aims to reduce the burden of influenza and other acute respiratory viruses in Europe. At the core of the group are twelve leading scientific experts from different disciplines: virology, immunology, microbiology, epidemiology, mathematical modelling, paediatrics, geriatrics and family medicine. ESWI is a partnership of these scientific experts, working in close collaboration with organisations of public health officials, healthcare professionals, and high-risk groups.
Exhibition Booth 10
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca
Exhibition Booth 12
Cellular Technology Ltd (CTL) offers instrumentation and consumable products for standardized/validated cellular assays
- High-throughput visible and fluorescent Analyzers
- Viral titer and microneutralization
- ELISPOT/FluoroSpot
- T and B cell ELISPOT Kits including for measuring Ferret B cell
- Human PBMC with variable Ig class and subclass usage against influenza and SARS-CoV-2 surface glycoproteins
- Contract Laboratory Services
Exhibition Booths 13 & 14
Vaxxas is developing a needle-free vaccine technology, the high-density microarray patch (HD-MAP). Easy to use, with potential to be more effective at lower doses and distributed without refrigeration, our technology could transform vaccination in the future. We're targeting initial applications in infectious diseases and oncology. Visit us at Options XII to learn more.
